l carnitine tmao koeth 2013 nature medicine γ-Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of L-Carnitine to Trimethylamine/Trimethylamine-N-Oxide as a Key Between
Trimethylamine Trimethylamine N Oxide as a Key Between Diet and Cardiovascular Diseases Cardiovascular Toxicology Springer Nature Link Dietary allicin reduces transformation of L carnitine to TMAO through impact on gut microbiota ScienceDirect A Multi omic Association Study of Trimethylamine N Oxide ScienceDirect Meat metabolizing bacteria in atherosclerosis Nature Medicine Gut microbiota metabolism of l carnitine and cardiovascular risk Atherosclerosis
Pay in 4 interest-free payments of $6.91 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 14 - Sep 19




